Aurinia Pharmaceuticals Inc. (AUPH)

Aurinia Pharmaceuticals Revenue

In the year 2023, Aurinia Pharmaceuticals had annual revenue of $175.51M with 30.95% growth. Revenue in the quarter ending December 31, 2023 was $45.10M with 58.59% year-over-year growth.

• Revenue (ttm): $175.51M
• Revenue Growth: +30.95%
• P/S Ratio: 4.24
• Revenue / Employee: $585,043
• Employees: 300
• Market Cap: 743.70M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	175.51M	41.48M	30.95%
Dec 31, 2022	134.03M	88.43M	193.89%
Dec 31, 2021	45.61M	-4.51M	-9.00%
Dec 31, 2020	50.12M	49.80M	15,660.38%
Dec 31, 2019	318.00K	-145.00K	-31.32%
Dec 31, 2018	463.00K	45.00K	10.77%
Dec 31, 2017	418.00K	245.00K	141.62%
Dec 31, 2016	173.00K	-62.00K	-26.38%
Dec 31, 2015	235.00K	-43.00K	-15.47%
Dec 31, 2014	278.00K	-691.00K	-71.31%
Dec 31, 2013	969.00K	-5.16M	-84.18%
Dec 31, 2012	6.13M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.